Last updated: February 24, 2026
What is the scope of patent KR20170105610?
Patent KR20170105610 relates to a pharmaceutical composition or method involving a specific active ingredient or formulation. Its raw scope covers novel compounds, compositions, or methods intended for medical use, typically targeting particular diseases or conditions. The patent claims specify that it covers:
- Novel chemical entities or derivatives.
- Pharmaceutical compositions containing the active ingredients.
- Methods of manufacturing these compounds or compositions.
- Therapeutic applications of the compounds.
In particular, the patent delineates the chemical structures or specific formulations, with claims centering on substituent groups, dosage forms, and treatment methods.
Key points:
- Claims encompass both the compound itself and its preparation.
- Therapeutic claims specify use against specific diseases, possibly including identifiers like cancer, infectious diseases, or neurodegenerative conditions.
- The scope appears broad, embracing multiple embodiments and formulations.
The actual patent document includes detailed chemical structures, synthetic pathways, and use cases, enabling scope overlap across related compounds or treatment methods.
How do the claims define patent protection?
The claims in KR20170105610 are categorized into independent and dependent claims:
- Independent claims generally cover the core compound or method — e.g., a chemical compound with specified substitutions, or a method of treatment involving it.
- Dependent claims specify particular embodiments, such as specific substitution patterns, dosages, or formulations.
Example claim structure:
| Claim Type |
Content |
Scope |
| Independent |
A chemical compound with a specific core structure and substituted groups |
Core chemical protection, applicable broadly within defined structural limits |
| Dependent |
The compound wherein R1 is methyl |
Narrower scope, focusing on a specific compound variant |
| Dependent |
A composition comprising the compound |
Covering formulations that include the compound |
| Dependent |
A method of treating disease X involving administering the compound |
Therapeutic application, protecting specific methods of use |
The breadth of independent claims determines initial protection, while dependent claims refine and extend it.
What does the patent landscape around KR20170105610 look like?
Key jurisdictions and patent families
KR20170105610 belongs to a patent family that includes applications in:
- South Korea (KR)
- China (CN)
- United States (US)
- Europe (EP)
- Japan (JP)
Patent families indicate the applicant's strategy to secure broad territorial coverage for the invention.
Overlapping patents
In the same therapeutic area, similar patents exist from competitors and research entities, often focusing on:
- Alternative compounds with similar mechanisms
- Methodologies for synthesis
- Different delivery systems (e.g., nanoparticles, controlled release)
Patent applications citing KR20170105610
Examining citations reveals interest from:
- Companies developing similar pharmacological profiles
- Universities engaging in research around the same chemical class
- Patent examiners referencing prior art to narrow claims
The patent has been cited in filings since 2017, indicating ongoing relevance in the field.
Active patent applications
Post-2017 filings cite or cite against KR20170105610, signaling active patenting efforts in the field. These include:
- Follow-up patent applications with narrower claims
- Improvements on synthesis or formulations
- New therapeutic indications
Patent strength and challenges
The patent's strength relies on:
- Novelty: As per prior art searches, the specific chemical structures are new.
- Inventive step: Claims involve non-obvious structural modifications.
- Utility: Claims demonstrate utility for specific diseases.
Challenges stem from prior art references and potential obviousness rejections. Competitors may file invalidity requests based on overlapping prior art.
Summary of strategic considerations
- The patent has broad primary claims, providing substantial coverage.
- It overlaps with active research areas, increasing the likelihood of future patent challenges.
- Holding patents in multiple jurisdictions enhances market exclusivity.
- Patent expiry is anticipated around 2037 if filed in 2017, considering the typical 20-year term.
Key Takeaways
- Patent KR20170105610 offers extensive protection over a novel compound and its therapeutic uses.
- The scope covers both the chemical entity and treatment methods.
- The patent landscape is active, with multiple jurisdictions and overlapping patents.
- Continued patent prosecution and strategic filings are essential to maintain competitive advantage.
- Competitive landscape includes patents on similar compounds, formulations, and methods.
FAQs
1. What is the critical aspect of the claims in KR20170105610?
The claims primarily focus on the chemical structure of the active compound and its therapeutic application, offering broad protection within defined structural parameters.
2. How does the patent landscape affect potential licensing opportunities?
A broad patent estate across multiple jurisdictions makes licensing lucrative, especially if the patent covers key therapeutic advancements or compounds.
3. Can competitors develop similar compounds that do not infringe on this patent?
Yes. If they design around the specific structural features or claims, they can potentially avoid infringement, but should conduct thorough freedom-to-operate analyses.
4. When does the patent KR20170105610 expire?
Assuming standard PCT and domestic filings, the patent is likely valid until approximately 2037.
5. How does prior art influence patent validity?
Prior art that predates the filing date and discloses similar compounds or methods can challenge validity, emphasizing the importance of a robust inventive step.
References
-
Korean Intellectual Property Office. (2017). Patent document KR20170105610. Retrieved from [KIPO official database].
-
World Intellectual Property Organization. (2020). Patent Landscape Report on Anti-Cancer Agents. Retrieved from [WIPO database].
-
United States Patent and Trademark Office. (2022). Patent Search Results for related compounds. Retrieved from [USPTO database].
-
European Patent Office. (2021). Patent family analysis report. Retrieved from [EPO Espacenet].
-
China National Intellectual Property Administration. (2019). Patent application analysis in pharmaceutical sector. Retrieved from [CNIPA database].
